Direct non-healthcare cost Productivity losses
Informal care Work days lost due to CINV
Transportation to hospital for CINV
treatment Lost income
resource utilisation for patients
experiencing any CINV episode
during the six-month period
preceding the survey. Furthermore,
the cost associated with severe
CINV episode management
was estimated by adopting
the National Health Service’s
perspective. Mean costs per patient
for treatment of a single severe
CINV episode were €389, €750
and €1017, respectively, in these
countries. 13 These data underline
that a complete control of CINV
is a reasonable approach for
prophylaxis from the economic
point of view. of the direct healthcare costs
incurred by healthcare systems and
patients and it represents a major
cost component in CINV-related
studies. Pharmacoeconomic studies
normally compare two or more
treatment alternatives or, in some
cases, they aim to assess costs
and consequences of one single
therapy. Another dimension that
helps frame the analysis is whether
both outcomes and costs or only
costs are considered.
In the latter case, the analysis
is considered a partial evaluation.
This type of analysis can take the
form of a cost-description or cost-
outcome description (that is, there
is no comparator), or of a cost
analysis (that is, two alternative
Pharmacoeconomics of CINV
Pharmaceutical treatment is one
hospitalpharmacyeurope.com | 2018 | 47